Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00005057
What this trial is testing

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
National Human Genome Research Institute (NHGRI)
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Ended earlyNCT02062359
What this trial is testing

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma

Who this might be right for
Metastatic CancerMetastatic Melanoma
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Ended earlyNCT00085059
What this trial is testing

Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 4
Not applicableStudy completedNCT00006243
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT01925118
What this trial is testing

Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2

Who this might be right for
Metastatic Malignant Melanoma and Renal Cell Carcinoma
Seoul National University Hospital 9
Testing effectiveness (Phase 2)Study completedNCT00514085
What this trial is testing

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 40
Early research (Phase 1)Looking for participantsNCT06332755
What this trial is testing

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)Head and Neck Squamous Cell Carcinoma(HNSCC)Renal Cell Carcinoma(RCC)+2 more
LG Chem 76
Not applicableStudy completedNCT01528774
What this trial is testing

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

Who this might be right for
Melanoma
Wolfram Samlowski 150
Early research (Phase 1)Study completedNCT02434354
What this trial is testing

A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma

Who this might be right for
Malignant Melanoma
Abramson Cancer Center at Penn Medicine 33
Not applicableStudy completedNCT01311466
What this trial is testing

Liver Transplantation and Uveal Malignant Melanoma

Who this might be right for
Uveal Malignant Melanoma
Oslo University Hospital 2
Testing effectiveness (Phase 2)Study completedNCT01335009
What this trial is testing

Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Eisai Inc. 76
Testing effectiveness (Phase 2)Ended earlyNCT01543464
What this trial is testing

Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients

Who this might be right for
Malignant Melanoma
Inge Marie Svane 41
Early research (Phase 1)Study completedNCT00412581
What this trial is testing

Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 28
Early research (Phase 1)Study completedNCT01673737
What this trial is testing

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Who this might be right for
Neoplasm Malignant
Sanofi 75
Not applicableLooking for participantsNCT06075524
What this trial is testing

Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Lung Carcinoma+7 more
Mayo Clinic 500
Early research (Phase 1)Study completedNCT01765569
What this trial is testing

A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma, Neoplasms
Hoffmann-La Roche 29
Testing effectiveness (Phase 2)Study completedNCT01189383
What this trial is testing

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Baylor Research Institute 20
Early research (Phase 1)Study completedNCT01052142
What this trial is testing

Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma

Who this might be right for
Melanoma
Lipotek Pty Ltd 12
Testing effectiveness (Phase 2)Study completedNCT00026221
What this trial is testing

Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 57
Next Page